Skip to content

Public FDA record

Z-0554-2022: HARDY DIAGNOSTICS CatScreen, 25dsk/vial

Recall record Z-0554-2022 for MEDLINE INDUSTRIES, LP - Northfield. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0554-2022
Company in FDA record
MEDLINE INDUSTRIES, LP - Northfield
FDA record creation date
Feb 2, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product stored incorrectly in temperature controlled setting instead of refrigeration.

Source facts

Action
Medline notified consignees on 12/01/2021, via first class mail letter titled URGENT RECALL NOTIFICATION. Customers were instructed to immediately check stock for affected product, quarantine any affected product on hand, complete and return the response form indicating product destroyed, and notify customers if the product was further distributed.
Initiated
2021-12-01
Root cause
Process control
Terminated
2023-01-09
Distribution
US Nationwide distribution in the state of California.
Recall number
Z-0554-2022
Recall status
Terminated
CDRH record ID
190646
FDA record created
2022-02-02
Recall event number
89151

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗